Search results
Results from the WOW.Com Content Network
Although a phase II trial for an injectable male contraceptive was halted in 2011 by an independent data safety monitoring board due likely to rare adverse effects experienced by some participants, [197] [67] leading many popular articles to suggest men could not tolerate side effects similar to those that many women endure on hormonal birth ...
A separate study conducted in part by the Male Contraceptive Initiative, showed that before the abortion ruling, 78% of men in the U.S. said they were interested in trying new birth control ...
In new drug trials, 34% to more than 80% of male participants were open to using a male contraceptive. The research also showed that “both men and women expressed the desire to share ...
A contraceptive developed by researchers at Weill Cornell Medical College could lead to a short-term, fast-acting option for men — without the side effects of hormonal pills.
Diagram showing the site of injection of the product Vasalgel, a vasectomy alternative. Reversible inhibition of sperm under guidance (RISUG), formerly referred to as the synthetic polymer styrene maleic anhydride (SMA), is the development name of a male contraceptive injection developed at IIT Kharagpur in India by the team of Dr. Sujoy K. Guha.
No male birth control product has made it to market, but over the past year, there has been promising early progress on new treatments — including a pill, a gel that’s rubbed onto the skin and ...
It is under development for use as a potential male hormonal contraceptive, specifically as a birth control pill for men. [2] [3] [4] The medication has been found to profoundly and rapidly reversibly suppress testicular testosterone production in men when taken by mouth once per day for a month.
"Many men say they would prefer a daily pill as a reversible contraceptive, rather than long-acting injections or topical gels."